Dr. Anke Fuchs
Person

Affiliations

Advanced Cellular Therapeutics (Junior Research Group)
- Research Group Leader
Center for Regenerative Therapies Dresden
- Academic Staff
- anke.fuchs1@tu-dresden.de

Identification Numbers

Scopus author ID	57200322070

CTGCT, Centre of Excellence for the Technologies of Gene and Cell Therapy: Collaborative translation of scientific discoveries into advanced treatments for neurological rare genetic diseases and cancer

Presen, D. M., Lainšček, D., Kinghorn, J., Sebestyen, Z., Kuball, J., Amini, L., Reinke, P., & 3 othersFuchs, A., Jerala, R. & Benčina, M., Jan 2025, In: Computational and Structural Biotechnology Journal. 27, p. 10-16 7 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

DEVELOPMENT OF A CLINICAL SCALE MANUFACTURING PROCESS FOR GENERATING ORGAN-TARGETED REVCAR REGULATORY T-CELLS

Lakshmi, K. & Fuchs, A., 12 Sept 2023.

Research output: Contribution to conferences › Poster › Contributed › peer-review

DISSECTING PHENOTYPICAL AND FUNCTIONAL DIFFERENCES BETWEEN REGULATORY T CELLS FROM ADULT PERIPHERAL BLOOD, UMBILICAL CORD BLOOD AND PEDIATRIC THYMUS

Santosh Nirmala, S. & Fuchs, A., 12 Sept 2023.

Research output: Contribution to conferences › Poster › Contributed › peer-review

DISTINCT ANTIBODY- AND T CELL-BASED IMMUNE RESPONSES TO SARS-COV-2 VACCINATION AND INFECTION IN PATIENTS TREATED WITH ANTI-CD19 CAR T CELL THERAPY

Marin Morales, J. M. & Fuchs, A., 12 Sept 2023.

Research output: Contribution to conferences › Poster › Contributed › peer-review

Next Generation Biobanking: Employing a Robotic System for Automated Mononuclear Cell Isolation

Fuchs, Y. F., Brunner, J., Weigelt, M., Schieferdecker, A., Morgenstern, R., Sturm, A., Winter, B., & 11 othersJambor, H., Stölzel, F., Ruhnke, L., von Bonin, M., Rücker-Braun, E., Heidenreich, F., Fuchs, A., Bonifacio, E., Bornhäuser, M., Poitz, D. M. & Altmann, H., Feb 2023, In: Biopreservation and biobanking. 21, 1, p. 106-110 5 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

View all research output (22)

TUD Young Investigator

Fuchs, A. (Recipient), 12 Sept 2023

Prize: Honors › Other Honors/Acknowledgements

4th place in the Science4Life Venture Cup "businessplan phase"

Sieweke, M. (Recipient), Englmeier, L. (Recipient), Fuchs, A. (Recipient) & Bornhäuser, M. (Recipient), 27 Jun 2023

Prize: Innovation/transfer prize

Science4Life - Venture Cup - Business Plan

Fuchs, A. (Recipient) & Englmeier, L. (Recipient), 27 Jun 2023

Prize: Innovation/transfer prize

Science4Life - Venture Cup - Concept Phase

Fuchs, A. (Recipient) & Englmeier, L. (Recipient), 15 Mar 2023

Prize: Innovation/transfer prize

Fuchs, A., Sieweke, M. & Englmeier, L.

26 Aug 2022

1 Media contribution

Press/Media

View all press/media (9)

Research Portal of the TU Dresden

Dr. Anke Fuchs
Person

Affiliations

Identification Numbers

Related content

CTGCT, Centre of Excellence for the Technologies of Gene and Cell Therapy: Collaborative translation of scientific discoveries into advanced treatments for neurological rare genetic diseases and cancer

DEVELOPMENT OF A CLINICAL SCALE MANUFACTURING PROCESS FOR GENERATING ORGAN-TARGETED REVCAR REGULATORY T-CELLS

DISSECTING PHENOTYPICAL AND FUNCTIONAL DIFFERENCES BETWEEN REGULATORY T CELLS FROM ADULT PERIPHERAL BLOOD, UMBILICAL CORD BLOOD AND PEDIATRIC THYMUS

DISTINCT ANTIBODY- AND T CELL-BASED IMMUNE RESPONSES TO SARS-COV-2 VACCINATION AND INFECTION IN PATIENTS TREATED WITH ANTI-CD19 CAR T CELL THERAPY

Next Generation Biobanking: Employing a Robotic System for Automated Mononuclear Cell Isolation

TUD Young Investigator

4th place in the Science4Life Venture Cup "businessplan phase"

Science4Life - Venture Cup - Business Plan

Science4Life - Venture Cup - Concept Phase

One of the ten winning teams in the Science4Life Venture Cup "concept phase"

Dr. Anke Fuchs Appointed TUD Young Investigator

Fourth Place for Makrophagen 2.0 at the Science4Life Start-up Competition

Start-up Project Makrophagen 2.0 One of the Winners of The Concept Phase of the Science4Life Venture Cup

Life-Saving Cell Therapies From Just Across the Street: CRTD Becomes Production Site for Virus-Specific T Cells for the University Hospital

From Lab to Business: CRTD Researchers receive BMBF GO-Bio Initial Funding